Whalesbook
Market Retreat Amid Geopolitical Fears
Indian stocks fell sharply by 2 percent on March 16, marking the third straight session of losses. This downturn was mainly driven by surging crude oil prices, fueled by escalating tensions and fears over a prolonged closure of the Strait of Hormuz. Market breadth was weak, with most stocks declining on the National Stock Exchange. Analysts expect continued market volatility and a downward trend as geopolitical tensions in West Asia persist. The Indian market has already seen major indices like the Sensex and Nifty crash approximately 8% in the preceding weeks of March 2026.
A Different Trading Approach
Amid widespread investor anxiety, financial experts have identified specific trading opportunities, pointing to stocks that may show resilience or have unique catalysts. Osho Krishan from Angel One noted NTPC Green Energy, recommending a buy near ₹95 with targets of ₹110-₹115. He cited a strong rebound from lows, supported by high trading volumes and positive technical indicators. Krishan also favored Tata Power, advising purchase around ₹390 for a target of ₹415-₹420, pointing to strong buying interest and a move above key average prices.
Rajesh Palviya of Axis Securities suggested a cautious approach for Federal Bank, recommending a sell strategy with targets at ₹250-₹240. He noted signs of a short-term trend reversal and negative momentum. However, Palviya also recommended buying JB Chemicals and Pharmaceuticals, aiming for ₹2,200-₹2,300, supported by a move above resistance levels and positive technical signals. Sterlite Technologies was also recommended for purchase, targeting ₹200-₹230, showing a strong uptrend and positive technical indicators.
Anshul Jain from Lakshmishree Investments supported Ajanta Pharma with a buy recommendation and a target of ₹3,415, highlighting its strong technical performance and relative strength in a weak market. Lumax Auto Technologies was also suggested for purchase around ₹1,434, targeting ₹1,655, after filling a price gap and showing strong recovery.
Stock Analysis: Valuations and Sector Trends
Examining the recommended stocks reveals a mix of growth plays and those showing relative defensive qualities. NTPC Green Energy trades at a Price-to-Earnings (P/E) ratio of about 148.60, reflecting high growth expectations in the renewable energy sector. Its Return on Equity (ROE) stands at around 3.85%.
Tata Power, with a Debt-to-Equity ratio of 1.7315, demonstrated significant revenue growth, reaching ₹65,478.24 crore in March 2025, with a Profit After Tax (PAT) of ₹3,982.04 crore.
Federal Bank, a mid-sized lender, exhibits a P/E of roughly 12x and reported a Q4 FY25 net profit of ₹1,030.2 crore. Analysts maintain 'Buy' ratings, with targets around ₹230.
JB Chemicals and Pharmaceuticals, despite a notable stake sale event by KKR in March 2025 which pressured its stock, reported a full-year FY25 net profit of ₹659.58 crore. Its P/E ratio is around 35x.
Sterlite Technologies presents a contrasting picture with a negative TTM P/E ratio of -110.465, suggesting current losses, and a low ROE of -6.28%. This suggests potential for a turnaround or speculative investment.
Ajanta Pharma, a consistent performer, trades at a P/E of approximately 37x and boasts an impressive ROE of nearly 25%. It has shown resilience, outperforming the Sensex in the week ending March 13, 2026, though its valuation is considered premium by some analysts.
Lumax Auto Technologies, in the auto ancillary space, trades at a P/E of around 49x, with an ROE of approximately 19%, reflecting its growth focus.
Historically, the market in March 2025 saw varied movements. Tata Power experienced gains around ₹375-₹380 on positive contract news, while Federal Bank saw marginal upticks. JB Chemicals faced a significant sell-off in late March 2025 following KKR's stake divestment.
The current geopolitical crisis amplifies risks for India, a country that imports 80-90% of its crude oil. This raises concerns about inflation, rupee depreciation, and a widening current account deficit.
Key Risks and Bear Case
While specific stocks are identified for potential gains, significant risks exist. Sterlite Technologies' negative profitability and ROE raise concerns about its turnaround potential, despite being debt-free. NTPC Green Energy's high P/E ratio of over 140x suggests it's priced for perfection, making it vulnerable to any growth slowdown or changes in renewable energy policy. Ajanta Pharma, though strong, trades at a premium valuation with a Price-to-Book (P/B) ratio of 8.77. This implies high market expectations that could lead to disappointment if growth slows.
Federal Bank, as a mid-sized lender, faces competition from larger banks and is vulnerable to interest rate changes and asset quality issues in a challenging economic climate. JB Chemicals' stock faced direct pressure from KKR's stake sale. Any further dilution or sentiment shifts could bring back selling pressure, despite good quarterly results.
The auto ancillary sector, including Lumax Auto, is vulnerable to rising raw material costs tied to oil prices and a potential slowdown in consumer demand.
Future Outlook
Market sentiment remains fragile, with volatility expected to persist due to ongoing geopolitical tensions and their impact on energy markets. A de-escalation in the Iran-US-Israel conflict could offer relief, but further escalation could prolong the market's downward pressure. Ajanta Pharma, however, is a notable outlier, receiving a 'Buy' rating from a majority of analysts and a consensus target price of around ₹3,207.58, suggesting confidence in its specific growth trajectory despite broader market woes. Federal Bank also retains 'Buy' ratings from prominent brokerages like Nuvama and Kotak.